Study on the investigational drug IAMA-6, placebo-controlled, administered to healthy adult volunteers, at single oral doses and at multiple ascending oral doses to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics of IAMA-6 and its interaction with food

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507454-33-00

Acronym

ECS_IAMA23_0101

Enrollment

Registered

2023-12-19

Start date

2024-01-08

Completion date

2024-10-10

Last updated

2024-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodevelopmental disorder

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Italy

None listed

Source: EU CTIS · Data processed: Feb 4, 2026